Patents by Inventor John Enquist

John Enquist has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SALTS AND POLYMORPHS OF CERTAIN MCL-1 INHIBITORS
    Publication number: 20250154168
    Abstract: The present disclosure relates salts and the crystalline forms of certain 3?,4,4?,5-tetrahydro-2H,2?H-spiro[benzo[b][1,4]oxazepine-3,1?-naphthalene] derivatives as well as pharmaceutical formulations and therapeutic uses thereof. The present disclosure also relates to preparing such salts, crystalline forms and pharmaceutical formulations.
    Type: Application
    Filed: October 25, 2024
    Publication date: May 15, 2025
    Inventors: John Enquist, Michael A. Ischay, Olga V. Lapina, David W. Lin, Christopher S. Regens, David A. Siler, Eric A. Standley, Sarah E. Wortman
  • METHODS AND INTERMEDIATES FOR PREPARING ANTIVIRAL PRODRUGS
    Publication number: 20250136603
    Abstract: The present invention is related to processes for preparing antiviral prodrugs, co-crystals, solvents, salts or combinations thereof, and related synthetic intermediate compounds.
    Type: Application
    Filed: June 26, 2024
    Publication date: May 1, 2025
    Inventors: Andrei Chtchemelinine, Gregory Cizio, Christopher Discolo, John Enquist, Lucas Man, Sean T. Neville, Keshab Sarma, Bing Shi, Leon X. Sun, Kevin S. Williamson
  • Salts and polymorphs of certain MCL-1 inhibitors
    Patent number: 12162896
    Abstract: The present disclosure relates salts and the crystalline forms of certain 3?,4,4?,5-tetrahydro-2H,2?H-spiro[benzo[b][1,4]oxazepine-3,1?-naphthalene] derivatives as well as pharmaceutical formulations and therapeutic uses thereof. The present disclosure also relates to preparing such salts, crystalline forms and pharmaceutical formulations.
    Type: Grant
    Filed: May 3, 2023
    Date of Patent: December 10, 2024
    Assignee: Gilead Sciences, Inc.
    Inventors: John Enquist, Michael A. Ischay, Olga V. Lapina, David W. Lin, Christopher S. Regens, David A. Siler, Eric A. Standley, Sarah E. Wortman
  • SALTS AND POLYMORPHS OF CERTAIN MCL-1 INHIBITORS
    Publication number: 20230357274
    Abstract: The present disclosure relates salts and the crystalline forms of certain 3?,4,4?,5-tetrahydro-2H,2?H-spiro[benzo[b][1,4]oxazepine-3,1?-naphthalene] derivatives as well as pharmaceutical formulations and therapeutic uses thereof. The present disclosure also relates to preparing such salts, crystalline forms and pharmaceutical formulations.
    Type: Application
    Filed: May 3, 2023
    Publication date: November 9, 2023
    Inventors: John Enquist, Michael A. Ischay, Olga V. Lapina, David W. Lin, Christopher S. Regens, David A. Siler, Eric A. Standley, Sarah E. Wortman